Tesamorelin(10mg)+Ipamorelin(5mg)
Description
Tesamorelin and Ipamorelin composite peptide formulation synergistically promotes growth hormone secretion for reducing visceral fat, improving body fat distribution, and preserving muscle mass.
Effects
Promotes growth hormone release; accelerates visceral fat metabolism; improves lean body mass ratio; boosts energy and metabolic rate; aids muscle gain and fat loss; may improve sleep quality.
Usage
Administer once daily via subcutaneous injection before bedtime. Typical dosage: Tesamorelin 2mg + Ipamorelin 300-500mcg. Cycle of 8-12 weeks. Recommended to combine with a low-calorie diet and resistance training. Rotate injection sites (abdomen, thigh).
Suitable for
Obese/overweight individuals requiring reduction of visceral fat; fitness enthusiasts aiming to improve body fat ratio; individuals seeking fat loss while preserving muscle; those with age-related decline in growth hormone.
Not suitable for
Pregnant and lactating women; patients with active malignant tumors; individuals allergic to any component; those with severe diabetes or poor blood glucose control; children and adolescents; individuals with pituitary dysfunction.
Ingredients
Tesamorelin (growth hormone-releasing factor analog); Ipamorelin (growth hormone-releasing peptide).
Storage
Store at 2-8°C (refrigerated), protect from light and freezing. Use immediately after reconstitution, or store at 2-8°C for no more than 24 hours.
Shelf life
36 months (lyophilized powder); 24 hours after reconstitution.
